An Immunohistochemical Study on the Role of CD83+ Dendritic Cells (DCs) in Malignant and Benign Lesions of the Human Cervix
Open Access
- 12 October 2024
- journal article
- Published by Springer Nature in Cureus
- Vol. 16 (10) , e71327
Abstract
Background Dendritic cells (DCs) are a group of cells that mainly function as antigen-presenting cells in the human body. Proper knowledge and understanding of such cells in the human cervix would be beneficial for understanding the role of CD83+ cells in benign and malignant lesions of the cervix. Materials and methods This retrospective study was performed on cervical specimens. After processing, the CD83+ cells were counted for every 20 high-power fields. The average count per high power field (HPF) was then calculated. The CD83+ cell distributions in cervicitis, cervical dysplasia, and cervical carcinoma were then analyzed. Results A total of 30 cervical specimens were studied. Of these, 16 were cervicitis and seven were squamous cell carcinoma. Vaginal bleeding was the most common presentation in 21 patients. The mean age was 44.7 years. The mean CD83+ DCs in benign lesions was 1.75 and in malignant tissues was 12.26 per HPF (P<0.001). The area under the curve suggested a 100% sensitivity and specificity of CD83 in distinguishing benign and malignant lesions. The receiver operating characteristic (ROC) curve indicated that the probability of malignancy is higher if the number of CD83+ DCS is more than 179.50/20 HPF. Conclusions Dendritic cells play a major role in the tumoricidal activities of the host cervical tissues. Malignant cervical tissue possesses a higher concentration of CD83+ DCs than benign ones, with 100% sensitivity and specificity. This research work on CD83+ DCs in the cervix would pave the way for further research on the immune functions of the human body.Keywords
This publication has 24 references indexed in Scilit:
- Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination InitiativeThe Lancet Global Health, 2022
- Molecular mechanisms of dendritic cell migration in immunity and cancerMedical Microbiology and Immunology, 2020
- Development of conventional dendritic cells: from common bone marrow progenitors to multiple subsets in peripheral tissuesMucosal Immunology, 2017
- Dendritic cell migration in health and diseaseNature Reviews Immunology, 2016
- Dendritic cells and immunotherapy for malignant diseaseBritish Journal of Haematology, 2001
- In Breast Carcinoma Tissue, Immature Dendritic Cells Reside within the Tumor, Whereas Mature Dendritic Cells Are Located in Peritumoral AreasJournal of Experimental Medicine, 1999
- Immunohistochemical and Ultrastructural Study of Langerhans's Cells in Squamous Cell Carcinoma of the CervixJournal of Obstetrics and Gynaecology Research, 1999
- Distribution of the dendritic cell in human organs and the incidence of GVHDTransplantation Proceedings, 1997
- CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells.Proceedings of the National Academy of Sciences, 1996
- Langerhans’cells in human cervical epithelium: effects of wart virus infection and intraepithelial neoplasiaBJOG: An International Journal of Obstetrics & Gynaecology, 1983